PPC
DGX icon

Park Place Capital’s Quest Diagnostics DGX Stock Holding History

Park Place Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-189
Closed -$25.2K – 871
2024
Q1 		$25.2K Hold
189
– – 0.01% 510
2023
Q4 		$26.1K Hold
189
– – 0.01% 495
2023
Q3 		$23K Hold
189
– – 0.01% 608
2023
Q2 		$26.6K Buy
189
+80
+73% +$11K 0.01% 600
2023
Q1 		$15.4K Hold
109
– – ﹤0.01% 692
2022
Q4 		$17K Buy
+109
New +$15.7K ﹤0.01% 680

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Park Place Capital's DGX Position: Q2 2024 in Review

Park Place Capital sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 189 shares — an estimated $25.2K sold.

Park Place Capital first reported a position in DGX in Q4 2022 and held it in 6 quarters. The position peaked at $26.6K in Q2 2023. 838 funds tracked by Wall St. Rank hold DGX as of Q2 2024.

  • Park Place Capital reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
  • Park Place Capital sold 189 Quest Diagnostics shares in Q2 2024, an estimated $25.2K.
  • Park Place Capital first reported a position in Quest Diagnostics in Q4 2022 and held it in 6 quarters.
  • Park Place Capital's Quest Diagnostics position peaked at $26.6K in Q2 2023.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.

Based on Park Place Capital's 13F filing for Q2 2024, filed 2 Jul 2024.